August 18
SoftWave Technical Service, LLC was founded as a research and development company and is a direct descendant of lithotripsy
SoftWave is committed to the scientific advancement of tissue healing and regeneration and the development of the most effective innovations to improve the quality of lives globally.
From chronic non-healing soft tissue wounds to chronic tendinopathies to myofascial syndrome, this technology is changing lives one softwave at a time. The SoftWave team is continually researching, testing, and educating so we can hit our goal of having SoftWave be available to anyone that needs to prevent or heal an injury — because no one should have to settle for living in pain or with a chronic injury.
— John Warlick, co-founder and CEO
At SoftWave, our commitment to innovation is at our core. Our patented technology sets us apart, reflecting years of research and development that drives superior patient outcomes. These patents aren’t just a mark of our ingenuity—they ensure that when you choose SoftWave, you’re offering a truly unique and advanced treatment option that can only be found with us.
Click below to access more patent info
SoftWave is used at leading national and international research and medical centers as well as professional sport organizations including: MLB, NFL, NBA, NHL, MLS, NCAA, PGA, USGA USATF, WNBA, Premier League, and UFC.
Alpharetta, Ga. (June 27, 2024) – Cardiac shockwave therapy leads to the regeneration of heart tissue after coronary bypass surgery, a study published in the prominent European Heart Journal showed. The study is co-authored by SoftWave TRT Medical Director Dr. Wolfgang Schaden, one of the original founders of the shockwave industry and pioneer of the regenerative applications of shockwaves.
